UROGENITAL NEOPLASMS
Clinical trials for UROGENITAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL NEOPLASMS trials appear
Sign up with your email to follow new studies for UROGENITAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Last-Chance treatment offered for advanced urogenital cancers
Disease control NO_LONGER_AVAILABLEThis program provided access to an investigational drug called NanoDoce for patients with urogenital cancers who could not join the main clinical trials. It was designed for people who had no other suitable treatment options available. The program is no longer accepting new patie…
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: NanOlogy, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC